IRF6
protein-codinginterferon regulatory factor 6, the group of Interferon regulatory factors
Gene summary
This gene encodes a member of the interferon regulatory transcription factor (IRF) family. Family members share a highly-conserved N-terminal helix-turn-helix DNA-binding domain and a less conserved C-terminal protein-binding domain. The encoded protein may be a transcriptional activator. Mutations in this gene can cause van der Woude syndrome and popliteal pterygium syndrome. Mutations in this gene are also associated with non-syndromic orofacial cleft type 6. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2011]
- VWS
- LPS
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~20.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0007334
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:1040010
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:1040010
Submitter: ClinGen
IRF6 was first reported in relation to autosomal dominant IRF6-related condition in 2002 (Kondo et al., PMID: 12219090). Per criteria outlined by the ClinGen Lumping and Splitting guidelines, we found no differences in molecular mechanisms or inheritance pattern. Also, the phenotype appears to be a spectrum, with potential features of cleft lip/palate, lip pits, webbing of the skin, other skin anomalies, and genital anomalies. Therefore, the following disease entities have been lumped into one disease entity: Popliteal pterygium syndrome (OMIM: 119500); Van der Woude syndrome (OMIM: 119300), and Orofacial cleft (OMIM: 608864). 19 variants (missense, nonsense, frameshift) that have been reported in at least 19 probands in 9 publications (PMIDs: 12219090, 12920575, 14618417, 14757865, 18478600, 19842205, 20184620, 20803643, 33906476) are included in this curation. More evidence is available in the literature (PMIDs: 25691407, 27252970), but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss-of-function. This gene-disease relationship is also supported by experimental evidence (mouse model, expression-level evidence, functional alteration data; PMIDs: 12219090, 17041601, 25784454). In summary, there is definitive evidence supporting the relationship between IRF6 and IRF6-related condition. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Craniofacial Malformations GCEP on the meeting date 1/18/2024 (SOP Version 10).
Inheritance Pattern: AD
Disease ID:MONDO:0007333
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0007334
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007333
Submitter: Ambry Genetics
Inheritance Pattern: Unknown
Disease ID:MONDO:0012141
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0005486
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0017435
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0007334
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0007333
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0019508
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007333
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0007334
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Dermatologic; Genitourinary; Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Variants may additionally act as susceptibility factors (rather than being involved in Mendelian-inherited dominant disease)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to IRF6 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006147.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 3 | 24 | 3 | 31 | |
| missense | 24 | 47 | 116 | 6 | 7 | 200 |
| nonsense | 26 | 8 | 34 | |||
| start loss | 1 | 1 | 2 | |||
| frameshift | 22 | 8 | 2 | 32 | ||
| splice donor/acceptor (+/-2bp) | 6 | 5 | 1 | 12 | ||
| Total | 79 | 70 | 122 | 30 | 10 | 311 |
Highest pathogenic variant AF is 0.0000043368195
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006138.1 | 7 | MANE Select | |
| Ensembl | ENSP00000355988.3 | 7 | MANE Select | |
| RefSeq | NP_001193625.1 | 6 | Standard | |
| Ensembl | ENSP00000403855.1 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Apoptosis
- Primary Focal Segmental Glomerulosclerosis FSGS
- Apoptotic Signaling Pathway
- Hypothetical Craniofacial Development Pathway
- the information processing pathway at the ifn beta enhancer
Biological Process
- cell cycle arrest
- negative regulation of cell population proliferation
- keratinocyte differentiation
- keratinocyte proliferation
- positive regulation of transcription, DNA-templated
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA binding
- DNA-binding transcription factor activity
- protein binding
Cellular Component
- nucleus
- cytoplasm
- cytosol
- cell junction
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000367021
- Coding exons
- 7
- Length
- 20430
- Individuals with no LoFs
- 125713
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 125714
- p
- 0.00000398
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.74 | 138 | 263 | 0.524 | 0.0000143 | 3098 |
| Missense (PolyPhen) | 23 | 112.37 | 0.20468 | 1304 | ||
| Synonymous | 1.70 | 79 | 101 | 0.785 | 0.00000542 | 883 |
| Loss of Function | 4.40 | 0 | 22.5 | 0.00 | 0.00000116 | 238 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.0000088 | 0.0000088 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Probable DNA-binding transcriptional activator. Key determinant of the keratinocyte proliferation-differentiation switch involved in appropriate epidermal development (By similarity). Plays a role in regulating mammary epithelial cell proliferation (By similarity). May regulate WDR65 transcription (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Van der Woude syndrome 1 (VWS1) [MIM:119300]: An autosomal dominant developmental disorder characterized by lower lip pits, cleft lip and/or cleft palate. {ECO:0000269|PubMed:12219090, ECO:0000269|PubMed:12920575, ECO:0000269|PubMed:14618417, ECO:0000269|PubMed:14640121, ECO:0000269|PubMed:15300989, ECO:0000269|PubMed:17122170, ECO:0000269|PubMed:18478600, ECO:0000269|PubMed:19036739}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Popliteal pterygium syndrome (PPS) [MIM:119500]: An autosomal dominant disorder characterized by oro-facial, skin and genital anomalies. Expressivity is variable. Clinical features include cleft lip/palate, lower lip cysts, syngnathia, congenital ankyloblepharon filiforme in some cases, bifid scrotum, hypoplastic scrotum, hypoplastic uterus, talipes equinovarus. {ECO:0000269|PubMed:12219090, ECO:0000269|PubMed:14640121, ECO:0000269|PubMed:19036739, ECO:0000269|PubMed:20803643}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Non-syndromic orofacial cleft 6 (OFC6) [MIM:608864]: A birth defect consisting of cleft lips with or without cleft palate. Cleft lips are associated with cleft palate in two-third of cases. A cleft lip can occur on one or both sides and range in severity from a simple notch in the upper lip to a complete opening in the lip extending into the floor of the nostril and involving the upper gum. {ECO:0000269|PubMed:15317890, ECO:0000269|PubMed:21082654}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.413
Intolerance Scores
- LoFtool
- 0.0332
- RVIS EVS
- -0.18
- RVIS percentile EVS
- 39.95
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.978
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |